Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
By Mill Chart
Last update: May 30, 2025
Curious about which S&P500 stocks are generating unusual volume on Friday? Find out below.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| COO | -14.67% | Today, COOPER COS INC/THE (NASDAQ:COO) stands out with a high volume of 4.57M shares. The share price decreased by 14.67%. In comparison to the average daily volume of the last 50 days, the current volume is 128.0% above. This suggests a notable change in trading activity. Yesterday the company had a press release: CooperCompanies Announces Second Quarter 2025 Results. |
| ULTA | 11.06% | Today's trading session witnessed an unusual volume of 2.97M shares for ULTA BEAUTY INC (NASDAQ:ULTA). ULTA is experiencing an advancement of 11.06% in its share price today. The average volume measured over 50 days is 891.89K, so this is 233.0% above the average volume. A press release (Ulta Beauty Announces First Quarter Fiscal 2025 Results) was released yesterday. |
| DELL | -3.35% | The trading volume of DELL TECHNOLOGIES -C (NYSE:DELL) today is 12.61M shares, which is considered unusual. This decline in share price leads to a decrease of 3.35%. The current trading volume is 66.18% above the average 50-day volume. This indicates a significant deviation from the average trading activity. Yesterday the company had a press release: Dell Technologies Delivers First Quarter Fiscal 2026 Financial Results. |
| REGN | -19.47% | The stock of REGENERON PHARMACEUTICALS (NASDAQ:REGN) has caught attention with a significant volume of 3.95M shares today. REGN is showing a decline of 19.47% in today's trading. This volume is 233.0% above the average 50 day volume. Yesterday the company had a press release: Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
570.59
+2.85 (+0.5%)
73.61
-1.16 (-1.55%)
479.67
+2.83 (+0.59%)
125.67
-1.16 (-0.91%)
Find more stocks in the Stock Screener
REGN Latest News and Analysis
11 days ago - ChartmillREGENERON PHARMACEUTICALS (NASDAQ:REGN) - A Potential Undervalued Biotech StockREGENERON PHARMACEUTICALS (NASDAQ:REGN) offers strong profitability, financial health, and an attractive valuation, making it a potential pick for value investors in the biotech sector.
